Skip to main content
Awiqli 700 U/mL injection, solution by Novo Nordisk Pharmaceutical Industries, LP
Awiqli, 700 U/mL, injection, solution Available on prescription only. Listed by Novo Nordisk Pharmaceutical Industries, LP.
Prescription only

Awiqli

Insulin icodec-abae

Listed by Novo Nordisk Pharmaceutical Industries, LP

Strength
700 U/mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Insulin Icodec 700 U/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 0169-3170
FDA application BLA761326
Package sizes listed 1
Marketed since August 2026

Other products containing Insulin Icodec

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Awiqli

Insulin icodec-abae

Strength
700 U/mL
Form
Injection, Solution
Rx only

Novo Nordisk Pharmaceutical Industries, LP

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.